Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Heska Corporation    HSKA

HESKA CORPORATION

(HSKA)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
10/20/2020 10/21/2020 10/22/2020 10/23/2020 10/26/2020 Date
104.42(c) 115.19(c) 120.78(c) 120.35(c) 114.63(c) Last
30 906 182 351 108 604 67 835 66 577 Volume
+0.66% +10.31% +4.85% -0.36% -4.75% Change
More quotes
Financials (USD)
Sales 2020 178 M - -
Net income 2020 -15,2 M - -
Net Debt 2020 - - -
P/E ratio 2020 -67,8x
Yield 2020 -
Sales 2021 211 M - -
Net income 2021 -2,88 M - -
Net Debt 2021 - - -
P/E ratio 2021 -378x
Yield 2021 -
Capitalization 1 137 M 1 137 M -
Capi. / Sales 2020 6,40x
Capi. / Sales 2021 5,40x
Nbr of Employees 386
Free-Float 93,8%
More Financials
Company
Heska Corporation sells veterinary diagnostic and specialty products. The Company operates through two segments: Core Companion Animal Health (CCA) and Other Vaccines, Pharmaceuticals and Products (OVP). The CCA segment includes, primarily for canine and feline use, blood testing instruments and supplies, digital imaging products, software and services, local and cloud-based data services, allergy testing and... 
More about the company
Notations Surperformance© of Heska Corporation
Trading Rating : Investor Rating :
More Ratings
All news about HESKA CORPORATION
08/24HESKA CORP : Change in Directors or Principal Officers, Financial Statements and..
AQ
08/10HESKA : Management's Discussion and Analysis of Financial Condition and Results ..
AQ
08/04HESKA CORP : Results of Operations and Financial Condition, Financial Statements..
AQ
08/04HESKA : 2Q Earnings Snapshot
AQ
05/28HESKA CORP : Changes in Registrant's Certifying Accountant, Financial Statements..
AQ
05/08HESKA : Management's Discussion and Analysis of Financial Condition and Results ..
AQ
05/07HESKA CORP : Results of Operations and Financial Condition (form 8-K)
AQ
05/07HESKA : 1Q Earnings Snapshot
AQ
05/06HESKA : Change in Directors or Principal Officers (form 8-K/A)
AQ
04/27HESKA CORP : Unregistered Sale of Equity Securities (form 8-K)
AQ
04/22HESKA CORP : Change in Directors or Principal Officers, Other Events (form 8-K)
AQ
04/09HESKA CORP : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
04/01HESKA CORP : Entry into a Material Definitive Agreement, Completion of Acquisiti..
AQ
02/28HESKA : Management's Discussion and Analysis of Financial Condition and Results ..
AQ
02/25HESKA CORP : Results of Operations and Financial Condition (form 8-K)
AQ
More news
News in other languages on HESKA CORPORATION

- No features available -

More news
Chart HESKA CORPORATION
Duration : Period :
Heska Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HESKA CORPORATION
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Average target price 107,13 $
Last Close Price 120,35 $
Spread / Highest target 3,86%
Spread / Average Target -11,0%
Spread / Lowest Target -36,0%
EPS Revisions
Managers
NameTitle
Kevin S. Wilson President, Chief Executive Officer & Director
Scott W. Humphrey Chairman
Nancy Wisnewski Chief Operating Officer & Executive Vice President
Catherine I. Grassman Chief Financial Officer & Executive Vice President
Glenn R. Frank Vice President-Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
HESKA CORPORATION25.44%1 137
ABBOTT LABORATORIES24.10%190 845
MEDTRONIC PLC-1.79%149 794
STRYKER CORPORATION5.70%83 347
BECTON, DICKINSON AND COMPANY-11.65%69 650
HOYA CORPORATION14.02%42 617